HIStalk Interviews Tom Borzilleri, CEO, InteliSys Health

No comments

Tell me about yourself and the company: I spent many years in the finance business. My first dive into the healthcare space was back in the late 1990s, having founded and operated the second-largest patient finance company in the country. As I progressed on through the years and had a successful exit of that company, I then moved into the PBM space in the mid-2000s.

popdevteamHIStalk Interviews Tom Borzilleri, CEO, InteliSys Health
read more

Readers Write: It’s Time for Drug Price Transparency

No comments

EHR vendors face a tough challenge in deciding which new features to develop and integrate for their next release and which ones to leave on the cutting room floor. The benefits of each potential enhancement must be weighed against the costs, usually measured in programming time. Moreover, features required for Meaningful Use and MIPS must be included, making the triage even more difficult.

popdevteamReaders Write: It’s Time for Drug Price Transparency
read more

Jury is Out on Possible Effects of CVS/Aetna Merger-Could result in fewer choices for Aetna enrollees, observers say

No comments

If the proposed $69-billion purchase of health insurer Aetna by CVS — a pharmacy chain that is also a pharmacy benefit manager (PBM) — is approved, it may be good news for the companies involved, but its potential effects on patients and providers are not so clear, experts say.

popdevteamJury is Out on Possible Effects of CVS/Aetna Merger-Could result in fewer choices for Aetna enrollees, observers say
read more